Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Environ Mol Mutagen ; 58(1): 4-18, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-28079927

RESUMEN

Epidemiologic studies and studies in rodents point to potential risks from developmental exposure to BPA on cardiometabolic diseases. Furthermore, it is becoming increasingly evident that the manifestation and severity of adverse outcomes is the result of interaction between developmental insults and the prevailing environment. Consistent with this premise, recent studies in sheep found prenatal BPA treatment prevented the adverse effects of postnatal obesity in inducing hypertension. The gene networks underlying these complex interactions are not known. mRNA-seq of myocardium was performed on four groups of four female sheep to assess the effects of prenatal BPA exposure, postnatal overfeeding and their interaction on gene transcription, pathway perturbations and functional effects. The effects of prenatal exposure to BPA, postnatal overfeeding, and prenatal BPA with postnatal overfeeding all resulted in transcriptional changes (85-141 significant differentially expressed genes). Although the effects of prenatal BPA and postnatal overfeeding did not involve dysregulation of many of the same genes, they affected a remarkably similar set of biological pathways. Furthermore, an additive or synergistic effect was not found in the combined treatment group, but rather prenatal BPA treatment led to a partial reversal of the effects of overfeeding alone. Many genes previously known to be affected by BPA and involved in obesity, hypertension, or heart disease were altered following these treatments, and AP-1, EGR1, and EGFR were key hubs affected by BPA and/or overfeeding. Environ. Mol. Mutagen. 58:4-18, 2017. © 2016 Wiley Periodicals, Inc.


Asunto(s)
Compuestos de Bencidrilo/toxicidad , Disruptores Endocrinos/toxicidad , Desarrollo Fetal/efectos de los fármacos , Miocardio/metabolismo , Obesidad/inducido químicamente , Fenoles/toxicidad , Efectos Tardíos de la Exposición Prenatal/inducido químicamente , Transcriptoma/efectos de los fármacos , Alimentación Animal , Animales , Peso al Nacer/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Femenino , Desarrollo Fetal/genética , Perfilación de la Expresión Génica , Interacción Gen-Ambiente , Edad Gestacional , Obesidad/genética , Obesidad/metabolismo , Embarazo , Efectos Tardíos de la Exposición Prenatal/genética , Efectos Tardíos de la Exposición Prenatal/metabolismo , Ovinos
2.
J Dent Res ; 93(1): 27-35, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24065634

RESUMEN

Most physiological processes in mammals display circadian rhythms that are driven by the endogenous circadian clock. This clock is comprised of a central component located in the hypothalamic suprachiasmatic nucleus and subordinate clocks in peripheral tissues. Circadian rhythms sustain 24-hour oscillations of a large number of master genes controlling the correct timing and synchronization of diverse physiological and metabolic processes within our bodies. This complex regulatory network provides an important communication link between our brain and several peripheral organs and tissues. At the molecular level, circadian oscillations of gene expression are regulated by a family of transcription factors called "clock genes". Dysregulation of clock gene expression results in diverse human pathological conditions, including autoimmune diseases and cancer. There is increasing evidence that the circadian clock affects tooth development, salivary gland and oral epithelium homeostasis, and saliva production. This review summarizes current knowledge of the roles of clock genes in the formation and maintenance of oral tissues, and discusses potential links between "oral clocks" and diseases such as head and neck cancer and Sjögren's syndrome.


Asunto(s)
Relojes Circadianos/fisiología , Enfermedades de la Boca/fisiopatología , Salud Bucal , Enfermedades Autoinmunes/genética , Proteínas CLOCK/genética , Relojes Circadianos/genética , Ritmo Circadiano/fisiología , Neoplasias de Cabeza y Cuello/genética , Humanos , Enfermedades de la Boca/genética , Síndrome de Sjögren/genética
3.
Oncogene ; 30(28): 3153-62, 2011 Jul 14.
Artículo en Inglés | MEDLINE | ID: mdl-21383698

RESUMEN

Mice with thyroid-specific expression of oncogenic BRAF (Tg-Braf) develop papillary thyroid cancers (PTCs) that are locally invasive and have well-defined foci of poorly differentiated thyroid carcinoma (PDTC). To investigate the PTC-PDTC progression, we performed a microarray analysis using RNA from paired samples of PDTC and PTC collected from the same animals by laser capture microdissection. Analysis of eight paired samples revealed a profound deregulation of genes involved in cell adhesion and intracellular junctions, with changes consistent with an epithelial-mesenchymal transition (EMT). This was confirmed by immunohistochemistry, as vimentin expression was increased and E-cadherin lost in PDTC compared with adjacent PTC. Moreover, PDTC stained positively for phospho-Smad2, suggesting a role for transforming growth factor (TGF)ß in mediating this process. Accordingly, TGFß-induced EMT in primary cultures of thyroid cells from Tg-Braf mice, whereas wild-type thyroid cells retained their epithelial features. TGFß-induced Smad2 phosphorylation, transcriptional activity and induction of EMT required mitogen-activated protein kinase (MAPK) pathway activation in Tg-Braf thyrocytes. Hence, tumor initiation by oncogenic BRAF renders thyroid cells susceptible to TGFß-induced EMT, through a MAPK-dependent process.


Asunto(s)
Progresión de la Enfermedad , Transición Epitelial-Mesenquimal , Sistema de Señalización de MAP Quinasas , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Proteínas Proto-Oncogénicas B-raf/metabolismo , Neoplasias de la Tiroides/patología , Factor de Crecimiento Transformador beta/metabolismo , Animales , Carcinoma , Carcinoma Papilar , Bovinos , Activación Enzimática/efectos de los fármacos , Transición Epitelial-Mesenquimal/efectos de los fármacos , Perfilación de la Expresión Génica , Humanos , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Ratones , Especificidad de Órganos , Fosforilación/efectos de los fármacos , Proteínas Proto-Oncogénicas B-raf/genética , Proteína Smad2/metabolismo , Cáncer Papilar Tiroideo , Glándula Tiroides/efectos de los fármacos , Glándula Tiroides/metabolismo , Glándula Tiroides/patología , Neoplasias de la Tiroides/genética , Neoplasias de la Tiroides/metabolismo , Transcripción Genética/efectos de los fármacos , Factor de Crecimiento Transformador beta/farmacología
4.
Food Chem Toxicol ; 47(6): 1051-7, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19425180

RESUMEN

Alachlor and butachlor are chloracetanilide herbicides that induce olfactory tumors in rats, whereas propachlor does not. The mechanism by which alachlor induces tumors is distinct from many other nasal carcinogens, in that alachlor induces a gradual de-differentiation of the olfactory mucosa (OM) to a more respiratory-like epithelium, in contrast to other agents that induce cytotoxicity, followed by an aberrant regenerative response. We studied biochemical and genomic effects of these compounds to identify processes that occur in common between alachlor- and butachlor-treated rats. Because we have previously shown that matrix metalloproteinase-2 (MMP2) is activated in OM by alachlor, in the present studies we evaluated both MMP2 activation and changes in OM gene expression in response to carcinogenic and non-carcinogenic chloracetanilide treatments. All three chloracetanilides activated MMP2, and >300 genes were significantly up- or downregulated between control and alachlor-treated rats. The most significantly regulated gene was vomeromodulin, which was dramatically upregulated by alachlor and butachlor treatment (>60-fold), but not by propachlor treatment. Except for similar gene responses in alachlor- and butachlor-treated rats, we did not identify clear-cut differences that would predict OM carcinogenicity in this study.


Asunto(s)
Acetanilidas/farmacología , Carcinógenos/farmacología , Mucosa Olfatoria/efectos de los fármacos , Acetamidas/farmacología , Acetamidas/toxicidad , Acetanilidas/toxicidad , Animales , Carcinógenos/toxicidad , Regulación hacia Abajo/efectos de los fármacos , Expresión Génica/efectos de los fármacos , Glicoproteínas/biosíntesis , Glicoproteínas/genética , Herbicidas/farmacología , Péptidos y Proteínas de Señalización Intercelular , Masculino , Metaloproteinasa 2 de la Matriz/biosíntesis , Proteínas de Transporte de Membrana/biosíntesis , Proteínas de Transporte de Membrana/genética , Neoplasias Nasales/inducido químicamente , Análisis de Secuencia por Matrices de Oligonucleótidos , Valor Predictivo de las Pruebas , Ratas , Ratas Long-Evans , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Relación Estructura-Actividad , Regulación hacia Arriba/efectos de los fármacos
5.
Endocr Relat Cancer ; 12(2): 319-34, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15947106

RESUMEN

RET/PTC rearrangements represent key genetic events involved in papillary thyroid carcinoma (PTC) initiation. The aim of the present study was to identify the early changes in gene expression induced by RET/PTC in thyroid cells. For this purpose, microarray analysis was conducted on PCCL3 cells conditionally expressing the RET/PTC3 oncogene. Gene expression profiling 48 h after activation of RET/PTC3 identified a statistically significant modification of expression of 270 genes. Quantitative PCR confirmation of 20 of these demonstrated 90% accuracy of the microarray. Functional clustering of genes with greater than or less than 1.75-fold expression change (86 genes) revealed RET/PTC3-induced regulation of genes with key functions in apoptosis (Ripk3, Tdga), cell-cell signaling (Cdh6, Fn1), cell cycle (Il24), immune and inflammation response (Cxcl10, Scya2, Il6, Gbp2, Oas1, Tap1, RT1Aw2, C2ta, Irf1, Lmp2, Psme2, Prkr), metabolism (Aldob, Ptges, Nd2, Gss, Gstt1), signal transduction (Socs3, Nf1, Jak2, Cpg21, Dusp6, Socs1, Stat1, Stat3, Cish) and transcription (Nr4a1, Junb, Hfh1, Runx1, Foxe1). Genes coding for proteins involved in the immune response and in intracellular signal transduction pathways activated by cytokines and chemokines were strongly represented, indicating a critical role of RET/PTC3 in the early modulation of the immune response.


Asunto(s)
Carcinoma Papilar/genética , Factores Inmunológicos/genética , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas/metabolismo , Proteínas Tirosina Quinasas Receptoras/genética , Proteínas Tirosina Quinasas Receptoras/metabolismo , Recombinación Genética , Neoplasias de la Tiroides/genética , Animales , Carcinoma Papilar/inmunología , Línea Celular Tumoral , Perfilación de la Expresión Génica , Proteínas Proto-Oncogénicas c-ret , Ratas , Neoplasias de la Tiroides/inmunología
6.
Dig Surg ; 18(3): 227-9, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11464018

RESUMEN

A case of obstructive acute cholecystitis following percutaneous liver biopsy is presented. The patient complained of intense and continuous pain in the right upper quadrant of the abdomen 2 days after the liver biopsy. On abdominal examination, Murphy's sign was present. Hemogram revealed a fall in the hematocrit level from 44 to 38 because of hemobilia. Ultrasonography showed a dilated gallbladder with moderate thickness of the wall and a blood clot of 20 x 9 mm inside. The patient was subjected to laparoscopic cholecystectomy. The acute inflammation of the gallbladder was secondary to obstruction of the cystic duct by the blood clot. The postoperative period was uneventful.


Asunto(s)
Biopsia con Aguja/efectos adversos , Colecistitis/etiología , Hemobilia/complicaciones , Hepatopatías/diagnóstico , Enfermedad Aguda , Adulto , Biopsia con Aguja/métodos , Coagulación Sanguínea , Femenino , Hemobilia/etiología , Humanos
7.
Appl Opt ; 36(22): 5288-97, 1997 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-18259344

RESUMEN

Intensified CCD cameras are increasingly being used in quantitative applications, which requires not only a greater understanding of their operation but also more detailed modeling to predict their performance more accurately. We have developed a model based on photon-noise-limited operation that incorporates the effects of the point spread function of the intensifier on signal-to-noise ratio. These effects are absent in other models, which renders them inadequate to model the camera performance properly. Calculations of noise-equivalent irradiance with our model are shown to be in good agreement with experimental results presented for two Xybion intensified cameras, Models GEN-III IMC and NIR DCIC intensified cameras.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA